The U.S. Food and Drug Administration (FDA) has granted traditional full approval to the CAR-T cell therapy Tecartus ...

For Bridget Hopkins, a nurse with a background in palliative care and hospice, the transition from caregiver to patient was a ...

A study led by researchers at a community hospital in Sapporo, Japan found that comprehensive genomic testing using a ...

A new study shows Signatera ctDNA testing may identify older patients with ER+/HER2- breast cancer who can manage their care ...

Christine Fader shares how her husband’s past trauma shaped his cancer treatment experience and why awareness and patient ...

For people diagnosed with actual early stage breast cancer, there would be an end date to their drug therapy too. Maybe a year of Herceptin (trastuzumab), maybe five years of anti-estrogen, something, ...

New ELCC 2026 data show longer survival, better brain metastases control and more personalized treatment options for patients ...

The phase 3 study, known as Neo-Healer or KN026–004, was an open-label, multicenter trial that randomly assigned ...

A couple opens up about navigating cancer care, advocating for themselves and balancing caregiver responsibilities with ...

Author and survivor Parul Somani shares how patients with breast cancer can find peace of mind when clinical certainty is ...

"Multiple myeloma is a marathon, not a sprint," Annamarie emphasized in an interview with CURE. To avoid the exhaustion that ...

In this segment, Dr. Gregory Vidal outlines what a typical first-line treatment plan looks like for patients with ER-positive ...